Infographics - Active Pharmaceutical Ingredients Market

Active pharmaceutical ingredients (APIs) and excipients are the two most important components in the production of a medication. API is the raw material, which is used in manufacturing medications, whereas excipient is a substance that functions as a medium to help the body absorb the drug such as lactose or mineral oil in a tablet. Active pharmaceutical ingredients are produced by using highly technological industrial processes, both during the research & development and commercial production phases. Such compounds are developed to provide pharmacological activity or other direct impacts on disease diagnosis, cure, mitigation, therapy, or prevention, or to change the structure and function of the body. The growth of active pharmaceutical ingredient (API) market can be attributed to certain factors such as increasing funding initiatives by the government across different regions. For instance, in May 2020, the U.S. Department of Health and Human Services (HHS) announced that it will provide a funding of US$ 354 million to Phlow Corporation, a pharmaceutical company, under a four-year contract to produce the active pharmaceutical ingredients (APIs) needed for medications to treat patients with COVID-19 and related illnesses.

Market Dynamics

The rising U.S Food & Drug Administration (FDA) approvals for drugs by pharmaceutical companies is further expected to boost the global active pharmaceutical ingredient (API) market growth during the forecast period. For instance, in December 2020, Eily Lilly received the U.S FDA clearance for several medicines including increased dosages of its Trulicity therapy for the treatment of type 2 diabetes, Cyramza for the treatment of metastatic Estimated Glomerular Filteration Rate (EGFR)-mutated non-small cell lung cancer, and tauvid for individuals diagnosed with Alzheimer's disease.

Key features of the study:

This report provides an in-depth analysis of the global active pharmaceutical ingredient (API) market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global active pharmaceutical ingredient (API) market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Dr. Reddy’s Laboratories Ltd., Novartis AG, Mylan N.V., Amneal Pharmaceuticals LLC, Lonza Group, Lupin Limited, Fresenius Kabi, Hikma Pharmaceuticals, Cipla Limited, Glenmark Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Endo International plc, Aurobindo Pharma Limited, Apotex Inc, Taro Pharmaceutical Industries Ltd, Stada Arzneimittel AG, Krka Pharmaceuticals, CordenPharma International, Evonik Industries AG, and Biological E. Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global active pharmaceutical ingredient (API) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global active pharmaceutical ingredient (API) market

Detailed Segmentation:

Global Active Pharmaceutical Ingredient (API) Market, By Product Type:
- Low Potent APIs
- High Potent APIs
Global Active Pharmaceutical Ingredient (API) Market, By Molecular Type:
- Small Molecules
- Large Molecules
Global Active Pharmaceutical Ingredient (API) Market, By Formulation:
- Oral
- Topical
- Injectable
- Drops
Global Active Pharmaceutical Ingredient (API) Market, By Application:
- Diabetes
- Oncology
- Cardiovascular
- CNS
- Analgesics
- Ophthalmic
- Respiratory
- Dermatology
- Others
Global Active Pharmaceutical Ingredient (API) Market, By Region:
- North America
  - By Product Type
    - Low Potent APIs
    - High Potent APIs
  - By Molecular Type
    - Small Molecules
    - Large Molecules
  - By Formulation
    - Oral
    - Topical
    - Injectables
    - Drops
  - By Application
    - Diabetes
    - Oncology
    - Cardiovascular
    - CNS
    - Analgesics
    - Ophthalmic
    - Respiratory
    - Dermatology
    - Others
  - By Country
    - U.S.
    - Canada
- Latin America
  - By Product Type
    - Low Potent APIs
    - High Potent APIs
  - By Molecular Type
    - Small Molecules
    - Large Molecules
  - By Formulation
    - Oral
    - Topical
    - Injectables
    - Drops
  - By Application
    - Diabetes
    - Oncology
    - Cardiovascular
    - CNS
    - Analgesics
    - Ophthalmic
    - Respiratory
    - Dermatology
    - Others
  - By Country
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Product Type
    - Low Potent APIs
    - High Potent APIs
  - By Molecular Type
    - Small Molecules
    - Large Molecules
  - By Formulation
    - Oral
    - Topical
    - Injectables
    - Drops
  - By Application
    - Diabetes
    - Oncology
    - Cardiovascular
    - CNS
    - Analgesics
    - Ophthalmic
    - Respiratory
    - Dermatology
    - Others
  - By Country
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Product Type
    - Low Potent APIs
    - High Potent APIs
  - By Molecular Type
    - Small Molecules
    - Large Molecules
  - By Formulation
    - Oral
    - Topical
    - Injectables
    - Drops
  - By Application
    - Diabetes
    - Oncology
    - Cardiovascular
    - CNS
    - Analgesics
    - Ophthalmic
    - Respiratory
    - Dermatology
    - Others
  - By Country
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Product Type
    - Low Potent APIs
    - High Potent APIs
  - By Molecular Type
    - Small Molecules
    - Large Molecules
  - By Formulation
    - Oral
    - Topical
    - Injectables
    - Drops
  - By Application
    - Diabetes
    - Oncology
    - Cardiovascular
    - CNS
    - Analgesics
    - Ophthalmic
    - Respiratory
    - Dermatology
    - Others
  - By Country
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Product Type
    - Low Potent APIs
    - High Potent APIs
  - By Molecular Type
    - Small Molecules
    - Large Molecules
  - By Formulation
    - Oral
    - Topical
    - Injectables
    - Drops
  - By Application
    - Diabetes
    - Oncology
    - Cardiovascular
    - CNS
    - Analgesics
    - Ophthalmic
    - Respiratory
    - Dermatology
    - Others
  - By Country/Region
    - South Africa
    - Central Africa
    - North Africa
Company Profiles
- Teva Pharmaceutical Industries Ltd.*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Pfizer, Inc.
- Reddy’s Laboratories Ltd.
- Novartis AG
- Mylan N.V.
- Amneal Pharmaceuticals LLC
- Lonza Group
- Lupin Limited
- Fresenius Kabi
- Hikma Pharmaceuticals
- Cipla Limited
- Glenmark Pharmaceuticals Limited
- Sun Pharmaceutical Industries Ltd.
- Endo International plc
- Aurobindo Pharma Limited
- Apotex Inc.
- Taro Pharmaceutical Industries Ltd
- Stada Arzneimittel AG
- Krka Pharmaceuticals
- CordenPharma International
- Evonik Industries AG
- Biological E. Limited

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Product Type
  - Market Snippet, By Molecular Type
  - Market Snippet, By Formulation
  - Market Snippet, By Application
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunity
- Impact Analysis
- Regulatory Scenario
- Market Trends
- API Patent Expiration
- Production Capability Analysis
- Mergers, Acquisitions and Collaboration Scenario
- Key Developments
- PEST Analysis
- Investments & Funding
- Production and Consumption Analysis
Global Active Pharmaceutical Ingredients (API) Market– COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
Global Active Pharmaceutical Ingredients (API) Market, By Product Type, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Low Potent APIs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- High Potent APIs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Global Active Pharmaceutical Ingredients (API) Market, By Molecular Type, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Small Molecules
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Large Molecules
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Global Active Pharmaceutical Ingredients (API) Market, By Formulation, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Oral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Topical
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Injectables
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Drops
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Global Active Pharmaceutical Ingredients (API) Market, By Formulation, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- Diabetes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Oncology
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Cardiovascular
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- CNS
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Bn)
- Analgesics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Bn)
- Ophthalmic
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Bn)
- Respiratory
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Bn)
- Dermatology
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Bn)
Global Active Pharmaceutical Ingredients (API) Market, By Region, 2018-2030, (US$ Bn)
- Introduction
  - Market Share Analysis, 2023 and 2030 (%)
  - Y-o-Y Growth Analysis, 2018–2030
  - Segment Trends
- North America
  - Introduction
  - Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018–2030, (US$ Bn)
  - Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018–2030, (US$ Bn)
  - Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018–2030, (US$ Bn)
  - Market Size and Forecast,Y-o-Y Growth and By End User, 2018–2030, (US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018–2030, (US$ Bn)
  - Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018–2030, (US$ Bn)
  - Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 –2030, (US$ Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast,Y-o-Y Growth and By Product Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2018 –2030, (US$ Bn)
  - Market Size and Forecast,Y-o-Y Growth and By Formulation, 2018–2030, (US$ Bn)
  - Market Size and Forecast,Y-o-Y Growth and By Application, 2018–2030, (US$ Bn)
  - Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 –2030, (US$ Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Teva Pharmaceutical Industries Ltd
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Pfizer, Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Dr. Reddy’s Laboratories Ltd
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Novartis AG
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Mylan N.V.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Amneal Pharmaceuticals LLC
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Lonza Group
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Lupin Limited
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Fresenius Kabi
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Hikma Pharmaceuticals
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Cipla Limited
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Glenmark Pharmaceuticals Limited
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Sun Pharmaceutical Industries Ltd
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Endo International plc
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Aurobindo Pharma Limited
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Apotex Inc.
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Taro Pharmaceutical Industries Ltd
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Stada Arzneimittel AG
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Krka Pharmaceuticals
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - CordenPharma International
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Evonik Industries AG
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
  - Biological E. Limited
    - Company Overview
    - Product Portfolio
    - Key Highlights
    - Financial Overview
    - Strategies
Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 38 market data tables and 33 figures on “Global Active Pharmaceutical Ingredients (API) Market” – Global forecast to 2030

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount